Mountain Crest Acquisition Corp. V
Extracted from this filing and checked against the source text.
Mountain Crest Acquisition Corp. V amended Amendment No. 3 to Business Combination Agreement with AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd., and AUM Biosciences Delaware Merger Sub, Inc. (effective 2023-04-19).
On April 19, 2023, SPAC, the Company, Holdco, Amalgamation Sub, and Merger Sub entered into an Amendment No. 3 to Business Combination Agreement (the “Amendment No. 3”) to ( 1) amend the definition of “Fully-Diluted Company Shares” and (2) update the Company Interests issued and paid-up as of the Amalgamation Effective Time from 9,841,118 Company Ordinary Shares to 9,125,538 Company Ordinary Shares.View on SEC.gov
Mountain Crest Acquisition Corp. V entered into Business Combination Agreement with AUM Biosciences Pte. Ltd. (effective 2022-10-19).
on October 19, 2022, Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time) (the “Business Combination Agreement”) with AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration number 201810204D (the “Company”).View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.